495 related articles for article (PubMed ID: 16988276)
1. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.
Zurawski DV; Mitsuhata C; Mumy KL; McCormick BA; Maurelli AT
Infect Immun; 2006 Oct; 74(10):5964-76. PubMed ID: 16988276
[TBL] [Abstract][Full Text] [Related]
2. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
[TBL] [Abstract][Full Text] [Related]
3. Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein.
Zurawski DV; Mumy KL; Faherty CS; McCormick BA; Maurelli AT
Mol Microbiol; 2009 Jan; 71(2):350-68. PubMed ID: 19017275
[TBL] [Abstract][Full Text] [Related]
4. MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system.
Kane CD; Schuch R; Day WA; Maurelli AT
J Bacteriol; 2002 Aug; 184(16):4409-19. PubMed ID: 12142411
[TBL] [Abstract][Full Text] [Related]
5. Host Cell Nuclear Localization of Shigella flexneri Effector OspF Is Facilitated by SUMOylation.
Jo K; Kim EJ; Yu HJ; Yun CH; Kim DW
J Microbiol Biotechnol; 2017 Mar; 27(3):610-615. PubMed ID: 27994213
[TBL] [Abstract][Full Text] [Related]
6. Shigella flexneri type III secreted effector OspF reveals new crosstalks of proinflammatory signaling pathways during bacterial infection.
Reiterer V; Grossniklaus L; Tschon T; Kasper CA; Sorg I; Arrieumerlou C
Cell Signal; 2011 Jul; 23(7):1188-96. PubMed ID: 21402152
[TBL] [Abstract][Full Text] [Related]
7. The Shigella type three secretion system effector OspF invades host nucleus by binding host importin α1.
Zhao H; Zhang Y; Wu P; Wang J; Li H
World J Microbiol Biotechnol; 2019 Apr; 35(5):71. PubMed ID: 31011826
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Cellular Mechanisms of Shigella flexneri Dissemination.
Agaisse H
Front Cell Infect Microbiol; 2016; 6():29. PubMed ID: 27014639
[TBL] [Abstract][Full Text] [Related]
9. IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexenri.
Hachani A; Biskri L; Rossi G; Marty A; Ménard R; Sansonetti P; Parsot C; Van Nhieu GT; Bernardini ML; Allaoui A
Microbes Infect; 2008 Mar; 10(3):260-8. PubMed ID: 18316224
[TBL] [Abstract][Full Text] [Related]
10. OspF directly attenuates the activity of extracellular signal-regulated kinase during invasion by Shigella flexneri in human dendritic cells.
Kim DW; Chu H; Joo DH; Jang MS; Choi JH; Park SM; Choi YJ; Han SH; Yun CH
Mol Immunol; 2008 Jun; 45(11):3295-301. PubMed ID: 18378312
[TBL] [Abstract][Full Text] [Related]
11. The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.
Faherty CS; Wu T; Morris CR; Grassel CL; Rasko DA; Harper JM; Shea-Donohue T; Fasano A; Barry EM
Gut Microbes; 2016 Nov; 7(6):486-502. PubMed ID: 27657187
[TBL] [Abstract][Full Text] [Related]
12. The Shigella flexneri OspB effector: an early immunomodulator.
Ambrosi C; Pompili M; Scribano D; Limongi D; Petrucca A; Cannavacciuolo S; Schippa S; Zagaglia C; Grossi M; Nicoletti M
Int J Med Microbiol; 2015 Jan; 305(1):75-84. PubMed ID: 25434600
[TBL] [Abstract][Full Text] [Related]
13. Identification of the cis-acting site involved in activation of promoters regulated by activity of the type III secretion apparatus in Shigella flexneri.
Mavris M; Sansonetti PJ; Parsot C
J Bacteriol; 2002 Dec; 184(24):6751-9. PubMed ID: 12446624
[TBL] [Abstract][Full Text] [Related]
14. Implications of Spatiotemporal Regulation of Shigella flexneri Type Three Secretion Activity on Effector Functions: Think Globally, Act Locally.
Campbell-Valois FX; Pontier SM
Front Cell Infect Microbiol; 2016; 6():28. PubMed ID: 27014638
[TBL] [Abstract][Full Text] [Related]
15. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
[TBL] [Abstract][Full Text] [Related]
16. Requirement of the Shigella flexneri virulence plasmid in the ability to induce trafficking of neutrophils across polarized monolayers of the intestinal epithelium.
McCormick BA; Siber AM; Maurelli AT
Infect Immun; 1998 Sep; 66(9):4237-43. PubMed ID: 9712773
[TBL] [Abstract][Full Text] [Related]
17. Formate Promotes
Koestler BJ; Fisher CR; Payne SM
mBio; 2018 Sep; 9(5):. PubMed ID: 30254126
[TBL] [Abstract][Full Text] [Related]
18. How Do the Virulence Factors of
Mattock E; Blocker AJ
Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050
[No Abstract] [Full Text] [Related]
19. Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli.
Hale TL; Sansonetti PJ; Schad PA; Austin S; Formal SB
Infect Immun; 1983 Apr; 40(1):340-50. PubMed ID: 6299962
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitination and degradation of GBPs by a Shigella effector to suppress host defence.
Li P; Jiang W; Yu Q; Liu W; Zhou P; Li J; Xu J; Xu B; Wang F; Shao F
Nature; 2017 Nov; 551(7680):378-383. PubMed ID: 29144452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
